Polyamine analogues down-regulate estrogen receptor α expression in human breast cancer cells

Yi Huang, Judith C. Keen, Allison Pledgie, Laurence J. Marton, Tao Zhu, Saraswati Sukumar, Ben Ho Park, Brian Blair, Keith Brenner, Robert A Casero, Nancy E. Davidson

Research output: Contribution to journalArticle

Abstract

The critical role of polyamines in cell growth has led to the development of a number of agents that interfere with polyamine metabolism including a novel class of polyamine analogues, oligoamines. Here we demonstrate that oligoamines specifically suppress the mRNA and protein expression of estrogen receptor α (ERα) and ERα target genes in ER-positive human breast cancer cell lines, whereas neither ERβ nor other steroid hormonal receptors are affected by oligoamines. The constitutive expression of a cytomegalovirus promoter-driven exogenous ERα in ER-negative MDA-MB-231 human breast cancer cells was not altered by oligoamines, suggesting that oligoamines specifically suppress ERα transcription rather than affect mRNA or protein stability. Further analysis demonstrated that oligoamines disrupted the DNA binding activity of Sp1 transcription factor family members to an ERα minimal promoter element containing GC/CA-rich boxes. Treatment of MDA-MB-231 cells with the JNK-specific inhibitor SP600125 or expression of the c-Jun dominant negative inhibitor TAM67 blocked the oligoamine-activated JNK/c-Jun pathway and enhanced oligoamine-inhibited ERα expression, suggesting that AP-1 is a positive regulator of ERα expression and that oligoamine-activated JNK/AP-1 activity may antagonize the down-regulation of ERα induced by oligoamines. Taken together, these results suggest a novel antiestrogenic mechanism for specific polyamine analogues in human breast cancer cells.

Original languageEnglish (US)
Pages (from-to)19055-19063
Number of pages9
JournalJournal of Biological Chemistry
Volume281
Issue number28
DOIs
StatePublished - Jul 14 2006

Fingerprint

Polyamines
Estrogen Receptors
Down-Regulation
Cells
Breast Neoplasms
Transcription Factor AP-1
Sp1 Transcription Factor
Protein Stability
Steroid Receptors
Messenger RNA
RNA Stability
Cytomegalovirus
Cell growth
Transcription
Metabolism
Proteins
Genes
Cell Line
DNA

ASJC Scopus subject areas

  • Biochemistry

Cite this

Polyamine analogues down-regulate estrogen receptor α expression in human breast cancer cells. / Huang, Yi; Keen, Judith C.; Pledgie, Allison; Marton, Laurence J.; Zhu, Tao; Sukumar, Saraswati; Park, Ben Ho; Blair, Brian; Brenner, Keith; Casero, Robert A; Davidson, Nancy E.

In: Journal of Biological Chemistry, Vol. 281, No. 28, 14.07.2006, p. 19055-19063.

Research output: Contribution to journalArticle

Huang, Y, Keen, JC, Pledgie, A, Marton, LJ, Zhu, T, Sukumar, S, Park, BH, Blair, B, Brenner, K, Casero, RA & Davidson, NE 2006, 'Polyamine analogues down-regulate estrogen receptor α expression in human breast cancer cells', Journal of Biological Chemistry, vol. 281, no. 28, pp. 19055-19063. https://doi.org/10.1074/jbc.M600910200
Huang, Yi ; Keen, Judith C. ; Pledgie, Allison ; Marton, Laurence J. ; Zhu, Tao ; Sukumar, Saraswati ; Park, Ben Ho ; Blair, Brian ; Brenner, Keith ; Casero, Robert A ; Davidson, Nancy E. / Polyamine analogues down-regulate estrogen receptor α expression in human breast cancer cells. In: Journal of Biological Chemistry. 2006 ; Vol. 281, No. 28. pp. 19055-19063.
@article{7beac806e3dd4238ba0c782e1b3d746a,
title = "Polyamine analogues down-regulate estrogen receptor α expression in human breast cancer cells",
abstract = "The critical role of polyamines in cell growth has led to the development of a number of agents that interfere with polyamine metabolism including a novel class of polyamine analogues, oligoamines. Here we demonstrate that oligoamines specifically suppress the mRNA and protein expression of estrogen receptor α (ERα) and ERα target genes in ER-positive human breast cancer cell lines, whereas neither ERβ nor other steroid hormonal receptors are affected by oligoamines. The constitutive expression of a cytomegalovirus promoter-driven exogenous ERα in ER-negative MDA-MB-231 human breast cancer cells was not altered by oligoamines, suggesting that oligoamines specifically suppress ERα transcription rather than affect mRNA or protein stability. Further analysis demonstrated that oligoamines disrupted the DNA binding activity of Sp1 transcription factor family members to an ERα minimal promoter element containing GC/CA-rich boxes. Treatment of MDA-MB-231 cells with the JNK-specific inhibitor SP600125 or expression of the c-Jun dominant negative inhibitor TAM67 blocked the oligoamine-activated JNK/c-Jun pathway and enhanced oligoamine-inhibited ERα expression, suggesting that AP-1 is a positive regulator of ERα expression and that oligoamine-activated JNK/AP-1 activity may antagonize the down-regulation of ERα induced by oligoamines. Taken together, these results suggest a novel antiestrogenic mechanism for specific polyamine analogues in human breast cancer cells.",
author = "Yi Huang and Keen, {Judith C.} and Allison Pledgie and Marton, {Laurence J.} and Tao Zhu and Saraswati Sukumar and Park, {Ben Ho} and Brian Blair and Keith Brenner and Casero, {Robert A} and Davidson, {Nancy E.}",
year = "2006",
month = "7",
day = "14",
doi = "10.1074/jbc.M600910200",
language = "English (US)",
volume = "281",
pages = "19055--19063",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "28",

}

TY - JOUR

T1 - Polyamine analogues down-regulate estrogen receptor α expression in human breast cancer cells

AU - Huang, Yi

AU - Keen, Judith C.

AU - Pledgie, Allison

AU - Marton, Laurence J.

AU - Zhu, Tao

AU - Sukumar, Saraswati

AU - Park, Ben Ho

AU - Blair, Brian

AU - Brenner, Keith

AU - Casero, Robert A

AU - Davidson, Nancy E.

PY - 2006/7/14

Y1 - 2006/7/14

N2 - The critical role of polyamines in cell growth has led to the development of a number of agents that interfere with polyamine metabolism including a novel class of polyamine analogues, oligoamines. Here we demonstrate that oligoamines specifically suppress the mRNA and protein expression of estrogen receptor α (ERα) and ERα target genes in ER-positive human breast cancer cell lines, whereas neither ERβ nor other steroid hormonal receptors are affected by oligoamines. The constitutive expression of a cytomegalovirus promoter-driven exogenous ERα in ER-negative MDA-MB-231 human breast cancer cells was not altered by oligoamines, suggesting that oligoamines specifically suppress ERα transcription rather than affect mRNA or protein stability. Further analysis demonstrated that oligoamines disrupted the DNA binding activity of Sp1 transcription factor family members to an ERα minimal promoter element containing GC/CA-rich boxes. Treatment of MDA-MB-231 cells with the JNK-specific inhibitor SP600125 or expression of the c-Jun dominant negative inhibitor TAM67 blocked the oligoamine-activated JNK/c-Jun pathway and enhanced oligoamine-inhibited ERα expression, suggesting that AP-1 is a positive regulator of ERα expression and that oligoamine-activated JNK/AP-1 activity may antagonize the down-regulation of ERα induced by oligoamines. Taken together, these results suggest a novel antiestrogenic mechanism for specific polyamine analogues in human breast cancer cells.

AB - The critical role of polyamines in cell growth has led to the development of a number of agents that interfere with polyamine metabolism including a novel class of polyamine analogues, oligoamines. Here we demonstrate that oligoamines specifically suppress the mRNA and protein expression of estrogen receptor α (ERα) and ERα target genes in ER-positive human breast cancer cell lines, whereas neither ERβ nor other steroid hormonal receptors are affected by oligoamines. The constitutive expression of a cytomegalovirus promoter-driven exogenous ERα in ER-negative MDA-MB-231 human breast cancer cells was not altered by oligoamines, suggesting that oligoamines specifically suppress ERα transcription rather than affect mRNA or protein stability. Further analysis demonstrated that oligoamines disrupted the DNA binding activity of Sp1 transcription factor family members to an ERα minimal promoter element containing GC/CA-rich boxes. Treatment of MDA-MB-231 cells with the JNK-specific inhibitor SP600125 or expression of the c-Jun dominant negative inhibitor TAM67 blocked the oligoamine-activated JNK/c-Jun pathway and enhanced oligoamine-inhibited ERα expression, suggesting that AP-1 is a positive regulator of ERα expression and that oligoamine-activated JNK/AP-1 activity may antagonize the down-regulation of ERα induced by oligoamines. Taken together, these results suggest a novel antiestrogenic mechanism for specific polyamine analogues in human breast cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=33745836681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745836681&partnerID=8YFLogxK

U2 - 10.1074/jbc.M600910200

DO - 10.1074/jbc.M600910200

M3 - Article

C2 - 16679312

AN - SCOPUS:33745836681

VL - 281

SP - 19055

EP - 19063

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 28

ER -